Patient co-payment for prescription medicines accross Europe - How do we compare?

Irish Medical Journal

Volumn 97, Issue 3, 2004, Pages 69-70

  Barry, Michael ^a   Tilson, L ^b   Ryan, M ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

COMMERCIAL PHENOMENA; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; ECONOMIC EVALUATION; EDITORIAL; EUROPE; FEE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; PHARMACY; PRESCRIPTION; REIMBURSEMENT;

COST SHARING; EUROPE; HEALTH EXPENDITURES; HUMANS; PRESCRIPTION FEES;

EID: 2942604377     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Feely J,. The influence of pharmacoeconomic factors on prescribing patterns in Ireland. Pharmacoeconomics 1992;299-106.
2. General Medical Services Payments Board. Report for the year ending 31st December 2002.
3. Kanavos P. Pharmaceutical pricing and reimbursement in Europe-2002.PJB Publications 2002.
4. Anonymous. Italy reveals more cost cutting plans. Scrip 2002;2755-3.
5. Barry M. Drug expenditure in Ireland 1991-2001. Ir. Med. J. 2002;95(10):294-295.